Experiment: 6SLY

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
2	2D 1H-13C HSQC	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
3	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
4	3D HNCA	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
5	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
6	3D HN(CO)CA	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
7	3D HN(CA)CO	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
8	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
9	3D HCCH-COSY	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
10	3D H(CC)(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
11	3D (H)CC(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
12	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850
13	3D 1H-13C NOESY	0.5 mM [U-100% 13C; U-100% 15N] TonB	95% H2O/5% D2O	20 mM	6	1 atm	303	Bruker AVANCE 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	850

NMR Refinement
Method	Details	Software
molecular dynamics		Amber

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNMR	2.4.1	CCPN
2	structure calculation	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
6	chemical shift assignment	TALOS	N	Cornilescu, Delaglio and Bax
3	refinement	Amber	14	Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
4	data analysis	PSVS	1.5	Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.